ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma

Huang, Zhen-Dong; Fu, Yong-Cheng; Liu, Shu-Yan; Mao, Ya-Juan; Zhang, Yan; Hu, Chao; Wei, Ren-Xiong*南方医科大学; 武汉大学
Frontiers in Immunology2022-7-28DOI: 10.3389/fimmu.2022.895465
5阅读
引用收藏
分享

摘要

N6-methyladenosine (m6A) methylation, one of the most crucial RNA modifications, has been proven to play a key role that affect prognosis of soft tissue sarcoma (STS). However, m6A methylation potential role in STS metabolic processes remains unknown. We comprehensively estimated the m6A metabolic molecular subtypes and corresponding survival, immunity, genomic and stemness characteristics based on 568 STS samples and m6A related metabolic pathways. Then, to quantify the m6A metabolic subtypes, machine learning algorithms were used to develop the m6A-metabolic Scores of individual patients. Finally, two distinct m6A metabolic subtypes (Cluster A and Cluster B) among the STS patients were identified. Compared to Cluster B subtype, the Cluster A subtype was mainly characterized by better survival advantages, activated anti-tumor immune microenvironment, lower gene mutation frequency and higher anti-PD-1 immunotherapy response rates. We also found that the m6A-metabolic Scores could accurately predict the molecular subtype of STS, prognosis, the abundance of immune cell infiltration, tumor metastasis status, sensitivity to chemotherapeutics and immunotherapy response. In general, this study revealed that m6A-regulated tumor metabolism processes played a key role in terms of prognosis of STS, tumor progression, and immune microenvironment. The identification of metabolic molecular subtypes and the construction of m6A-metabolic Score will help to more effectively guide immunotherapy, metabolic therapy and chemotherapy in STS.

学科与关键词

关键词
m6A modificationcancer metabolismtumor microenvironmentmolecular classificationmachine learningimmunotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-07-28
卷期
第 13 卷
页码
895465
DOI
10.3389/fimmu.2022.895465
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • H

    Huang, Zhen-Dong (第一作者)

    wuhan univ · southern med univ

  • F

    Fu, Yong-Cheng

    hubei univ med

查看全部 7 位作者收起作者
  • L

    Liu, Shu-Yan

    hubei univ med

  • M

    Mao, Ya-Juan

    hubei univ med

  • Z

    Zhang, Yan

    hubei univ med

  • H

    Hu, Chao

    wuhan univ

  • W

    Wei, Ren-Xiong (通讯)

    wuhan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417